HAIKOU, China, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ —
China Pharma Holdings, Inc. (“China Pharma”) (NYSE Amex:
CPHI), which develops, manufactures, and markets specialty
pharmaceutical products in China, today announced that it plans to
release its fiscal year 2010 financial results before the market
opens on Thursday, March 3, 2011.
The Company will hold a conference call at 8:30 am ET on March
3, 2011 to discuss fiscal year 2010 results. Listeners may access
the call by dialing 1-800-265-0241 or 1-617-847-8704 for
international callers, access code: 49845306. A webcast will also
be available through CPHI’s website at http://www.chinapharmaholdings.com.
A replay of the call will be accessible through March 10, 2011 by
dialing 1-888-286-8010 or 1-617-801-6888 for international callers,
access code: 57630593.
About China Pharma Holdings, Inc.China Pharma Holdings, Inc.
is a specialty pharmaceutical company with rapidly growing profit
that develops, manufactures, and markets treatments for a wide
range of high incidence and high mortality conditions in China,
including cardiovascular, CNS, infectious, and digestive diseases.
The Company’s cost-effective, high margin business model is driven
by market demand and supported by eight scalable GMP-certified
product lines covering the major dosage forms. In addition, the
Company has a broad and expanding distribution network across 30
provinces, municipalities and autonomous regions. The Company is
registered in Delaware, USA. Hainan Helpson Medical &
Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan
Province, China, is a wholly owned subsidiary of China Pharma
Holdings, Inc. For more information about China Pharma Holdings,
Inc., please visit http://www.chinapharmaholdings.com.For